8 results
6-K
EX-99.1
OPT
Opthea Limited
4 Apr 24
Current report (foreign)
6:46pm
Angiomatous Proliferation (RAP) detected/not detected at baseline Polypoidal Choroidal Vasculopathy (PCV) detected/not detected at baseline
Demographic
6-K
EX-99.1
OPT
Opthea Limited
3 Apr 24
Current report (foreign)
6:06am
at baseline Polypoidal Choroidal Vasculopathy (PCV) detected/not detected at baseline
Demographic/Baseline Disease Characteristic 2.0 mg OPT-302 + ranibizumab
6-K
EX-99.1
OPT
Opthea Limited
4 Mar 24
Current report (foreign)
6:06am
Analysis mITT Population Allocation ITT Population Screening
Demographic/Baseline Disease Characteristic 2.0 mg OPT-302 + ranibizumab n=123 Mean Age
6-K
EX-99.1
OPT
Opthea Limited
11 Jan 24
Current report (foreign)
6:01am
Demographics and Baseline Characteristics Demographic/Baseline Disease Characteristic Sham + ranibizumab n=121 0.5 mg OPT-302 + ranibizumab n=122 2.0
6-K
EX-99.1
6s8z1
24 Aug 23
Current report (foreign)
6:16am
F-3
EX-1.2
vqdffpdg ukh8
1 Feb 22
Shelf registration (foreign)
12:00am
- Prev
- 1
- Next